Ventolin and Dermatitis atopic aggravated - a phase IV clinical study of FDA data

Summary:

Dermatitis atopic aggravated is reported as a side effect among people who take Ventolin (albuterol), especially for people who are male, 40-49 old, also take Xolair, and have Eczema.

The phase IV clinical study analyzes which people have Dermatitis atopic aggravated when taking Ventolin. It is created by eHealthMe based on reports of 50,731 people who have side effects when taking Ventolin from the FDA, and is updated regularly.

What is Ventolin?

Ventolin has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 51,849 Ventolin users. Check the latest studies of Ventolin.

What is Dermatitis atopic aggravated?

Dermatitis atopic aggravated (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 610 drugs and 179 conditions by eHealthMe. Check the latest studies of Dermatitis atopic aggravated.

On Jul, 17, 2026

50,731 people reported to have side effects when taking Ventolin.
Among them, 60 people (0.12%) have Dermatitis atopic aggravated.

Could Ventolin cause Dermatitis atopic aggravated?

Among these 60 people:

What is the gender of people who have Dermatitis atopic aggravated when taking Ventolin? *

female: 35 %
male: 65 %

What is the age of people who have Dermatitis atopic aggravated when taking Ventolin? *

What are other drugs people take besides Ventolin? *

What are other side effects people have besides Dermatitis atopic aggravated? *

Rashes (redness): 32 people, 53.33%
Dyspnea (difficult or laboured breathing): 24 people, 40.00%
Itching: 23 people, 38.33%
Cataract (clouding of the lens inside the eye): 21 people, 35.00%
Weight Decreased: 20 people, 33.33%
Gastroenteritis (inflammation of stomach and intestine): 16 people, 26.67%
Swallowing Difficulty: 16 people, 26.67%
Pain: 16 people, 26.67%
Malaise (a feeling of general discomfort or uneasiness): 15 people, 25.00%
Weakness: 15 people, 25.00%

What are the existing conditions these people have? *

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 7 people, 11.67%
Allergic Rhinitis: 2 people, 3.33%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 3.33%
Pain: 2 people, 3.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 1.67%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 1.67%
Cough: 1 person, 1.67%
Depression: 1 person, 1.67%
Dyspnea (difficult or laboured breathing): 1 person, 1.67%
Stress And Anxiety: 1 person, 1.67%

* Approximation only. Some reports may have incomplete information.

Do you take Ventolin and have Dermatitis atopic aggravated?

- Check whether Dermatitis atopic aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ventolin:

Ventolin (51,849 reports)

Browse all side effects of Ventolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis atopic aggravated:

Dermatitis atopic aggravated (610 drugs)

Browse all the conditions that are associated with Dermatitis atopic aggravated:

Dermatitis atopic aggravated (179 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol (the active ingredients of Ventolin) and Ventolin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.